Castleark Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-262,507
Closed -$4.22M 306
2023
Q2
$4.22M Buy
262,507
+29,140
+12% +$480K 0.19% 127
2023
Q1
$4.06M Buy
+233,367
New +$3.32M 0.2% 116
2021
Q1
Sell
-126,241
Closed -$6.8M 357
2020
Q4
$6.8M Sell
126,241
-120,356
-49% -$5.44M 0.25% 110
2020
Q3
$9.1M Sell
246,597
-82,849
-25% -$3.08M 0.36% 77
2020
Q2
$10.2M Sell
329,446
-26,274
-7% -$728K 0.44% 48
2020
Q1
$9.82M Sell
355,720
-10,906
-3% -$327K 0.58% 47
2019
Q4
$10.7M Sell
366,626
-135,875
-27% -$3.24M 0.43% 61
2019
Q3
$9.61M Sell
502,501
-74,620
-13% -$1.75M 0.39% 88
2019
Q2
$12.7M Sell
577,121
-84,494
-13% -$1.85M 0.49% 54
2019
Q1
$13.5M Sell
661,615
-12,619
-2% -$219K 0.51% 48
2018
Q4
$8.5M Buy
674,234
+383,300
+132% +$5.71M 0.36% 81
2018
Q3
$4.47M Buy
+290,934
New +$4.02M 0.13% 202
2017
Q1
Sell
-971,332
Closed -$8.32M 400
2016
Q4
$8.32M Buy
971,332
+78,550
+9% +$673K 0.27% 132
2016
Q3
$7.34M Sell
892,782
-105,615
-11% -$886K 0.22% 143
2016
Q2
$8.03M Buy
998,397
+70,650
+8% +$566K 0.26% 115
2016
Q1
$6.25M Buy
927,747
+278,780
+43% +$1.83M 0.2% 137
2015
Q4
$5.11M Buy
+648,967
New +$4.75M 0.15% 161
2013
Q4
Sell
-572,400
Closed -$2.98M 361
2013
Q3
$2.98M Buy
+572,400
New +$1.61M 0.08% 205

Other funds holding NEO

Castleark Management's NEO Position: Q3 2023 in Review

Castleark Management sold out of NeoGenomics (NEO) in Q3 2023, closing a stake of 262,507 shares — an estimated $4.22M sold.

Castleark Management first reported a position in NEO in Q3 2013 and held it in 18 quarters. The position peaked at $13.5M in Q1 2019. 284 funds tracked by Wall St. Rank hold NEO as of Q3 2023.

  • Castleark Management reported no remaining NeoGenomics position as of Q3 2023 after selling out during the quarter.
  • Castleark Management sold 262,507 NeoGenomics shares in Q3 2023, an estimated $4.22M.
  • Castleark Management first reported a position in NeoGenomics in Q3 2013 and held it in 18 quarters.
  • Castleark Management's NeoGenomics position peaked at $13.5M in Q1 2019.
  • 284 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2023.

Based on Castleark Management's 13F filing for Q3 2023, filed 15 Nov 2023.